Prime Medicine, Inc. - COMMON STOCK (PRME)

CUSIP: 74168J101

Q1 2024 13F Holders as of 31 Mar 2024

Security identity 2 facts
Shares outstanding
181,672,212
Holder snapshot 9 facts
Share change
+17,979,343
Put/Call ratio
115%
Reported price per share
$7.00
Number of holders
112
Value change
+$125,445,462
Number of buys
60
Number of sells
45

Security key

74168J101

Report period

Q1 2024

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Alphabet Inc.
13D/G signal
Evidence rows
15
Latest as of
31 Dec 2023
13F 3/4/5 Lead comparable stake: 6.5% Showing 1-6 of 15 holder rows.

Rank 3 holder

FMR LLC

3/4/5 13F
Ownership
2.2%
Position
$126.7M
Holder Evidence Ownership % Position 12M Net Δ As of
Alphabet Inc.
13F
Company
13F
6.5%
$105,101,732
11,862,498 shares
31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
2.2%
$35,926,512
4,054,911 shares
31 Dec 2023
FMR LLC
3/4/5 13F
Other* · Company
2.2%
from 13F
$126,699,612
8,462,946 shares
24 Oct 2022
BlackRock Finance, Inc.
13F
Company
13F
2.1%
$33,478,556
3,778,618 shares
31 Dec 2023
Amova Asset Management Americas, Inc.
13F
Company
13F
1.9%
$31,178,597
3,519,029 shares
31 Dec 2023
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
1.9%
$31,178,597
3,519,029 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
66,659,039
Rows available
112
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
102
Q1 2024 holders
112
Holder diff
10
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .